Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-042336
Filing Date
2004-03-15
Accepted
2004-03-15 16:49:26
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 816389
3 STOCK PLEDGE AND LOAN AGREEMENT, DATED SEPTEMBER 1, 1999 dex1034.htm EX-10.34 56436
4 STOCK PLEDGE AND LOAN AGREEMENT DATED NOVEMBER 13, 2000 dex1035.htm EX-10.35 56316
5 SUBSIDIARIES dex21.htm EX-21 1796
6 CONSENT OF ERNST & YOUNG LLP dex23.htm EX-23 2080
7 CERTIFICATION PURSUANT TO SECTION 302 dex311.htm EX-31.1 9798
8 CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 dex32.htm EX-32 4056
  Complete submission text file 0001193125-04-042336.txt   949066
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

EIN.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-21990 | Film No.: 04670133
SIC: 2836 Biological Products, (No Diagnostic Substances)